MediciNova, Inc.
MNOV
$1.32
$0.00760.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -86.54% | -- | -- | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -86.54% | -- | -- | -100.00% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -98.17% | -- | -- | -100.00% | -- |
| SG&A Expenses | 11.71% | 7.42% | 4.54% | -10.29% | -13.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.19% | 15.07% | 16.29% | 2.92% | -19.21% |
| Operating Income | -35.47% | -26.49% | -28.03% | -12.60% | 26.68% |
| Income Before Tax | -44.66% | -32.70% | -28.89% | -8.20% | 34.39% |
| Income Tax Expenses | 83.33% | 83.33% | 83.33% | 7.14% | 7.14% |
| Earnings from Continuing Operations | -44.67% | -32.71% | -28.91% | -8.20% | 34.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.67% | -32.71% | -28.91% | -8.20% | 34.38% |
| EBIT | -35.47% | -26.49% | -28.03% | -12.60% | 26.68% |
| EBITDA | -35.56% | -26.56% | -28.08% | -12.60% | 26.74% |
| EPS Basic | -44.68% | -32.71% | -28.95% | -8.25% | 34.40% |
| Normalized Basic EPS | -44.62% | -32.68% | -28.85% | -8.17% | 34.38% |
| EPS Diluted | -42.40% | -30.75% | -30.75% | -8.20% | 33.84% |
| Normalized Diluted EPS | -44.62% | -32.68% | -28.85% | -8.17% | 34.38% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |